| Title: | "[Human plague and pneumonic plague : pathogenicity, epidemiology, clinical presentations and therapy]" |
| Address: | "Zentrales Institut des Sanitatsdienstes der Bundeswehr, Ingolstadter Landstr. 102, 85748, Munchen, Deutschland, juliariehm@bundeswehr.org" |
| Journal Title: | Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz |
| DOI: | 10.1007/s00103-015-2167-9 |
| ISSN/ISBN: | 1437-1588 (Electronic) 1436-9990 (Linking) |
| Abstract: | "Yersinia pestis is a highly pathogenic gram-negative bacterium and the causative agent of human plague. In the last 1500 years and during three dreaded pandemics, millions of people became victims of Justinian's plague, the Black Death, or modern plague. Today, Y. pestis is endemic in natural foci of Asian, African and American countries. Due to its broad dissemination in mammal species and fleas, eradication of the pathogen will not be possible in the near future. In fact, plague is currently classified as a 're-emerging disease'. Infection may occur after the bite of an infected flea, but also after oral ingestion or inhalation of the pathogen. The clinical presentations comprise the bubonic and pneumonic form, septicemia, rarely pharyngitis, and meningitis. Most human cases can successfully be treated with antibiotics. However, the high transmission rate and lethality of pneumonic plague require international and mandatory case notification and quarantine of patients. Rapid diagnosis, therapy and barrier nursing are not only crucial for the individual patient but also for the prevention of further spread of the pathogen or of epidemics. Therefore, WHO emergency schedules demand the isolation of cases, identification and surveillance of contacts as well as control of zoonotic reservoir animals and vectors. These sanctions and effective antibiotic treatment usually allow a rapid containment of outbreaks. However, multiple antibiotic resistant strains of Y. pestis have been isolated from patients in the past. So far, no outbreaks with such strains have been reported" |
| Keywords: | Anti-Bacterial Agents/*therapeutic use Humans Incidence Pandemics/*prevention & control/*statistics & numerical data Plague/diagnosis/*mortality/*therapy Quarantine/*methods Risk Factors Survival Rate; |
| Notes: | "MedlineRiehm, Julia M Loscher, Thomas ger Review Germany 2015/05/13 Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2015 Jul; 58(7):721-9. doi: 10.1007/s00103-015-2167-9" |
